Agios Pharmaceuticals, Inc. (AGIO)
NASDAQ: AGIO · IEX Real-Time Price · USD
29.11
-0.01 (-0.03%)
Mar 28, 2024, 10:36 AM EDT - Market open

Agios Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 2011
Net Income
-352.09-231.81,605-327.37-411.47-346.03-314.67-198.47-117.73-53.5
Upgrade
Depreciation & Amortization
17.3418.5618.7818.7716.627.176.435.713.341.37
Upgrade
Share-Based Compensation
44.7749.353.5161.658.0573.3647.8142.0931.9611.51
Upgrade
Other Operating Activities
-6.08-145.53-2,084.323.05100.65-38.92-24.8189.245.48-18.72
Upgrade
Operating Cash Flow
-296.06-309.48-407.32-243.94-236.16-304.42-285.2338.56-76.95-59.35
Upgrade
Capital Expenditures
0.33-3.92-5.74-14.11-12.03-6.99-4.63-9.92-20.16-2.22
Upgrade
Acquisitions
0131.7800000000
Upgrade
Change in Investments
256.75115.39-548.4290.66103.61-266.84-53.28-109.44148.47-331.69
Upgrade
Other Investing Activities
-17.5-1,803------0.57
Upgrade
Investing Cash Flow
239.58243.261,24976.5591.58-273.83-57.91-119.35128.31-333.34
Upgrade
Share Issuance / Repurchase
5.432.68-765.1911.32289.72546.42284.47170.016.58335.88
Upgrade
Debt Issued / Paid
0-0.33-0.58-0.34-0.1100000
Upgrade
Other Financing Activities
---261.52289.61-0.390.64-0.23-0.21-0.72
Upgrade
Financing Cash Flow
5.432.35-765.77272.5579.22546.02285.11169.786.37335.16
Upgrade
Net Cash Flow
-51.05-63.8775.6946.5110.43-32.22-58.0388.9957.73-57.53
Upgrade
Free Cash Flow
-295.74-313.4-413.06-258.05-248.18-311.41-289.8628.65-97.11-61.57
Upgrade
Free Cash Flow Margin
-1102.55%-2200.81%----329.93%-673.92%40.99%-164.27%-94.20%
Upgrade
Free Cash Flow Per Share
-5.31-5.72-6.83-3.74-4.14-5.42-6.220.73-2.60-1.83
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).